Factors Influencing Cardiac Rehabilitation Success
Assessment of the Effectiveness of Comprehensive Cardiac Rehabilitation and Identification of Factors Modulating Its Results
1 other identifier
observational
150
0 countries
N/A
Brief Summary
Cardiovascular diseases, especially after life-saving surgeries, require comprehensive cardiac rehabilitation (CR). We know that the effectiveness of CR varies among patients. The main goal of this study is to understand which factors-psychological, physical, cognitive, biochemical, and hormonal-influence the success and long-term durability of the recovery process. These findings will help us create more effective and personalized treatment programs. Who is Being Studied and What is Being Assessed? Study Group: 150 patients of both sexes, aged 50-80 years, hospitalized in the cardiac rehabilitation ward, primarily after Coronary Artery Bypass Grafting (CABG). Study Period: Patients will be assessed at the start of their hospital stay, at the end of rehabilitation, and again 3-6 months after discharge. Key Assessment Areas (Modulating Factors) Physical Status and Fitness: Exercise tolerance (6-Minute Walk Test). Muscle strength (handgrip), balance, and gait. Body composition (analysis of muscle mass and fat tissue). Respiratory function and diaphragm mobility (ultrasound). Psychological and Cognitive Factors: Assessment of anxiety, depression, and general mental well-being. Evaluation of cognitive functions (memory, concentration) following cardiac surgery. Sleep Problems (OSA): Assessment of the risk and severity of Obstructive Sleep Apnea (OSA), which is common in cardiac patients. Analysis of OSA risk factors related to oral health (dentition, microbiome) and craniofacial structure. Biological Markers: Hormonal tests (e.g., testosterone, estradiol) and their correlation with psycho-physical condition and the rehabilitation process. Analysis of metabolic and muscle-related biomarkers (e.g., myokines: irisin, myostatin).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 1, 2025
CompletedStudy Start
First participant enrolled
January 3, 2026
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 20, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2029
January 9, 2026
December 1, 2025
3.5 years
December 1, 2025
January 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Physical Capacity (6MWT)
Distance walked in 6 minutes measured in meters using the 6-Minute Walk Test (6MWT). The test reflects objective functional improvement in physical capacity.
Baseline (start of hospitalization/T0) and Post-Rehab (end of cardiac rehabilitation/T1, approximately 3-4 weeks later)
Secondary Outcomes (5)
Change in Psychological Status (HADS)
Baseline, Post-Rehab (approx. 3-4 weeks later), and Follow-up (3-6 months after discharge
Diaphragm Thickness
Baseline and Post-Rehab (approx. 3-4 weeks later).
Change in Diaphragm Mobility
Baseline and Post-Rehab (approx. 3-4 weeks later).
Change in Montreal Cognitive Assessment (MoCA) Score
Baseline, Post-Rehab (approx. 3-4 weeks later), and Follow-up (3-6 months after discharge).
Change in Mini-Mental State Examination (MMSE) Score
Baseline, Post-Rehab (approx. 3-4 weeks later), and Follow-up (3-6 months after discharge).
Other Outcomes (3)
Change in Apnea-Hypopnea Index (AHI)
Baseline and Post-Rehab (approx. 3-4 weeks later).
Change in Sex Hormones Concentration
Baseline (fasting) and Post-Rehab (fasting, approx. 3-4 weeks later)
Change in Myokines and Metabolic Markers Concentration
Baseline (fasting) and Post-Rehab (fasting, approx. 3-4 weeks later).
Interventions
This study is an observational, non-pharmacological, multi-domain assessment of patients undergoing standard comprehensive cardiac rehabilitation (CR) following CABG surgery. The intervention involves a detailed, longitudinal, three-stage evaluation (Baseline, Post-Rehab, 3-6 Month Follow-up) of the factors influencing CR outcomes. The CR itself is a standard hospital-based program, but the research intervention is distinguished by its holistic focus on measuring and correlating: Objective Functional Data: Exercise capacity (6MWT), muscle strength, diaphragm function (USG), and postural stability. Multifactorial Co-morbidities: Screening for Obstructive Sleep Apnea (OSA) (NOX-T3), Cognitive Dysfunction (MoCA/MMSE), and the role of oral health in OSA risk. Biological \& Hormonal Profile: Measuring Sex Hormones (Testosterone, Estradiol) and Myokines (Irisin, Myostatin) to understand personalized metabolic and adaptive responses to the rehabilitation program. The intervention aims to
Eligibility Criteria
Male patients aged 50-80 years who have undergone coronary artery bypass graft (CABG) surgery and are currently hospitalized for cardiac rehabilitation. The study population includes individuals from a single clinical center in Poland.
You may qualify if:
- Male patients aged 50-80 years
- Hospitalization in the Cardiac Rehabilitation Ward
- Undergone coronary artery bypass graft (CABG) surgery within the last 30 days
- Written, informed consent to participate in the study
You may not qualify if:
- Type II diabetes treated with insulin
- Neuro-surgical operation in the last 6 months
- Aneurysms of the cerebral arteries and aorta
- Recurrent ischemic stroke (Cerebral Vascular Accident)
- Presence of a pacemaker
- Current treatment with testosterone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
December 1, 2025
First Posted
January 9, 2026
Study Start
January 3, 2026
Primary Completion (Estimated)
June 20, 2029
Study Completion (Estimated)
July 1, 2029
Last Updated
January 9, 2026
Record last verified: 2025-12